Medication and suicide risk in schizophrenia: A nested case–control study

2013 ◽  
Vol 150 (2-3) ◽  
pp. 416-420 ◽  
Author(s):  
Johan Reutfors ◽  
Shahram Bahmanyar ◽  
Erik G. Jönsson ◽  
Lena Brandt ◽  
Robert Bodén ◽  
...  
2015 ◽  
Vol 207 (2) ◽  
pp. 175-176 ◽  
Author(s):  
Carlene King ◽  
Jane Senior ◽  
Roger T. Webb ◽  
Tim Millar ◽  
Mary Piper ◽  
...  

SummaryThe elevated risk of suicide in prison and after release is a well-recognised and serious problem. Despite this, evidence concerning community-based offenders' suicide risk is sparse. We conducted a population-based nested case–control study of all people in a community justice pathway in England and Wales. Our data show 13% of general population suicides were in community justice pathways before death. Suicide risks were highest among individuals receiving police cautions, and those having recent, or impending prosecution for sexual offences. Findings have implications for the training and practice of clinicians identifying and assessing suicidality, and offering support to those at elevated risk.


2020 ◽  
Author(s):  
Young Choi ◽  
Eun-Cheol Park

Abstract Background Schizophrenia patients have shorter life expectancy relative to that of the general population, and their suicide risk is reportedly higher. Although antipsychotic discontinuation rates are high, antipsychotic treatment has been associated with lower suicide mortality, and patients who do not use antipsychotics are at greater risk of suicide relative to those who use the medication. Furthermore, maintenance treatment with antipsychotic drugs protects schizophrenia patients from relapse. However, little is known about antipsychotic discontinuation, suicide risk, or the time during which suicide risk is highest following antipsychotic discontinuation. Therefore, this study investigated whether discontinuity of antipsychotics is associated with suicide in schizophrenia patients.Methods A population-based nested case-control study was conducted using the Korean National Health Insurance claims database (2002-2013). From the study population of 7,519 patients with the diagnosis of schizophrenia and at least one antipsychotics described, we identified 154 suicide cases and 760 matched controls. We calculated the days after last prescribed medication so that discontinuity of antipsychotics was defined. Conditional logistic regression were used to examine the association between discontinuity of antipsychotics and suicide adjusting for possible confounding covariates.Results Suicide risk was particularly high during the first thirty days after discharge after stopping antipsychotics compared with current user after adjusting all covariates (AOR: 4.667, 95% CI: 2.425–8.984).Conclusion Maintenance treatment with antipsychotics could help to reduce suicide risk. The results indicated that there is a need to monitor schizophrenia patients following antipsychotic discontinuation.


2016 ◽  
Vol 31 (4) ◽  
pp. 341-345 ◽  
Author(s):  
Johan Reutfors ◽  
Eric Clapham ◽  
Shahram Bahmanyar ◽  
Lena Brandt ◽  
Erik G. Jönsson ◽  
...  

2016 ◽  
Vol 17 (1) ◽  
Author(s):  
Michael Doyle ◽  
David While ◽  
Pearl L. H. Mok ◽  
Kirsten Windfuhr ◽  
Darren M. Ashcroft ◽  
...  

BMJ Open ◽  
2020 ◽  
Vol 10 (7) ◽  
pp. e037365
Author(s):  
Philippe Mortier ◽  
Gemma Vilagut ◽  
Beatriz Puértolas Gracia ◽  
Ana De Inés Trujillo ◽  
Itxaso Alayo Bueno ◽  
...  

IntroductionSuicide attempts represent an important public health burden. Centralised electronic health record (EHR) systems have high potential to provide suicide attempt surveillance, to inform public health action aimed at reducing risk for suicide attempt in the population, and to provide data-driven clinical decision support for suicide risk assessment across healthcare settings. To exploit this potential, we designed the Catalonia Suicide Risk Code Epidemiology (CSRC-Epi) study. Using centralised EHR data from the entire public healthcare system of Catalonia, Spain, the CSRC-Epi study aims to estimate reliable suicide attempt incidence rates, identify suicide attempt risk factors and develop validated suicide attempt risk prediction tools.Methods and analysisThe CSRC-Epi study is registry-based study, specifically, a two-stage exposure-enriched nested case–control study of suicide attempts during the period 2014–2019 in Catalonia, Spain. The primary study outcome consists of first and repeat attempts during the observation period. Cases will come from a case register linked to a suicide attempt surveillance programme, which offers in-depth psychiatric evaluations to all Catalan residents who present to clinical care with any suspected risk for suicide. Predictor variables will come from centralised EHR systems representing all relevant healthcare settings. The study’s sampling frame will be constructed using population-representative administrative lists of Catalan residents. Inverse probability weights will restore representativeness of the original population. Analysis will include the calculation of age-standardised and sex-standardised suicide attempt incidence rates. Logistic regression will identify suicide attempt risk factors on the individual level (ie, relative risk) and the population level (ie, population attributable risk proportions). Machine learning techniques will be used to develop suicide attempt risk prediction tools.Ethics and disseminationThis protocol is approved by the Parc de Salut Mar Clinical Research Ethics Committee (2017/7431/I). Dissemination will include peer-reviewed scientific publications, scientific reports for hospital and government authorities, and updated clinical guidelines.Trial registration numberNCT04235127.


Sign in / Sign up

Export Citation Format

Share Document